NASDAQ: AUTLAutolus Therapeutics PLC Stock Ownership - Who owns Autolus Therapeutics?
Insider buying vs selling
Have Autolus Therapeutics PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when AUTL insiders and whales buy or sell their stock.
AUTL Shareholders
What type of owners hold Autolus Therapeutics PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Mak Capital One LLC | 12.63% | 33,621,487 | $55.81M | Institution |
| Blackstone Inc | 7.70% | 20,485,611 | $34.01M | Institution |
| Syncona Portfolio Ltd | 6.25% | 16,640,720 | $27.62M | Institution |
| Armistice Capital LLC | 5.94% | 15,800,000 | $26.23M | Institution |
| Tetragon Partners GP Ltd | 3.57% | 9,500,000 | $15.77M | Institution |
| Schroder Investment Management Group | 3.57% | 9,489,345 | $15.75M | Institution |
| Frazier Life Sciences Management LP | 1.67% | 4,447,910 | $7.38M | Institution |
| Bnp Paribas Asset Management Holding Sa | 1.26% | 3,361,156 | $5.58M | Institution |
| Laurion Capital Management LP | 1.25% | 3,316,626 | $5.51M | Institution |
| Renaissance Technologies LLC | 0.86% | 2,299,499 | $3.82M | Institution |
AUTL vs Biotech Stocks
Autolus Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.